Adage Capital Partners Portfolio holdings
AUM
$63.1B
1-Year Est. Return
32.57%
1 Year Est. Return
+32.57%
AUM
$59.3B
AUM Growth
+$5.38B
(+10%)
Holding
971
Top Buys
| 1 | +$120M | |
| 2 | +$120M | |
| 3 | +$120M | |
| 4 |
Johnson Controls International
JCI
|
+$114M |
| 5 |
Ionis Pharmaceuticals
IONS
|
+$108M |
Top Sells
| 1 | +$169M | |
| 2 | +$163M | |
| 3 | +$144M | |
| 4 |
Vertex Pharmaceuticals
VRTX
|
+$139M |
| 5 |
Royal Caribbean
RCL
|
+$130M |
Sector Composition
| 1 | Technology | 29.16% |
| 2 | Healthcare | 13.82% |
| 3 | Financials | 12.25% |
| 4 | Consumer Discretionary | 9.51% |
| 5 | Industrials | 8.68% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
326
Core Scientific
CORZ
$5.13B
| $32.4M | 0.05% |
1,900,000
+900,000
|
|
||
327
Gates Industrial
GTES
$5.73B
| $32.3M | 0.05% |
+1,400,585
|
|
||
328
Zions Bancorporation
ZION
$8.09B
| $32M | 0.05% |
+616,248
|
|
||
329
TE Connectivity
TEL
$67.9B
| $31.9M | 0.05% |
189,043
+48,345
|
|
||
330
Phillips Edison & Co
PECO
$4.39B
| $31.9M | 0.05% |
910,000
-5,000
|
|
||
331
News Corp Class A
NWSA
$14.3B
| $31.8M | 0.05% |
1,070,099
-224,500
|
|
||
332
Kenvue
KVUE
$32.5B
| $31.8M | 0.05% |
1,518,958
-130,800
|
|
||
333
Idexx Laboratories
IDXX
$58B
| $31.8M | 0.05% |
+59,201
|
|
||
334
Fortive
FTV
$17B
| $31.7M | 0.05% |
607,522
+326,340
|
|
||
335
Fulcrum Therapeutics
FULC
$490M
| $31.6M | 0.05% |
4,589,000
+1,589,000
|
|
||
336
Truist Financial
TFC
$60.7B
| $31.6M | 0.05% |
734,364
+23,400
|
|
||
337
Valero Energy
VLO
$54B
| $31.2M | 0.05% |
231,900
-7,000
|
|
||
338
Biogen
BIIB
$26.5B
| $31.1M | 0.05% |
247,937
+177,170
|
|
||
339
CoStar Group
CSGP
$29.3B
| $31.1M | 0.05% |
386,400
+1,800
|
|
||
340
Delta Air Lines
DAL
$44.1B
| $30.9M | 0.05% |
628,011
-17,600
|
|
||
341
Ingersoll Rand
IR
$31.5B
| $30.7M | 0.05% |
369,492
-55,095
|
|
||
342
Centuri Holdings
CTRI
$2.45B
| $30.7M | 0.05% |
+1,369,228
|
|
||
343
Align Technology
ALGN
$11.1B
| $30.6M | 0.05% |
161,811
+34,423
|
|
||
344
Hilton Worldwide
HLT
$65.1B
| $30.6M | 0.05% |
114,900
+28,900
|
|
||
345
Rio Tinto
RIO
$121B
| $30.6M | 0.05% |
524,602
+444,602
|
|
||
346
Aura Biosciences
AURA
$400M
| $30.6M | 0.05% |
4,881,125
|
|
||
347
Kyndryl
KD
$6.01B
| $30.4M | 0.05% |
725,000
-540,000
|
|
||
348
Dyne Therapeutics
DYN
$2.87B
| $30.4M | 0.05% |
+3,191,000
|
|
||
349
Canadian Pacific Kansas City
CP
$66.6B
| $30.4M | 0.05% |
383,028
-461,787
|
|
||
350
Tango Therapeutics
TNGX
$1.29B
| $30.2M | 0.05% |
+5,905,349
|
|